These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1120981)

  • 1. Catechol O-methyltransferase. 6. Affinity labeling with N-haloacetyl-3,5-dimethoxy-4-hydroxyphenylalkylamines.
    Borchardt RT; Thakker DR
    J Med Chem; 1975 Feb; 18(2):152-8. PubMed ID: 1120981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affinity labeling of catechol O-methyltransferase by N-haloacetyl derivatives of 3,5-dimethoxy-4-hydroxyphenylethylamine and 3,4-dimethoxy-5-hydroxyphenylethylamine. Kinetics of inactivation.
    Borchardt RT; Thakker DR
    Biochemistry; 1975 Oct; 14(20):4543-51. PubMed ID: 240407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Affinity labeling of catechol-O-methyltransferase with N-iodoacetyl-3,5-dimethoxy-4-hydroxyphenylethylamine.
    Borchardt RT; Thakker D
    Biochem Biophys Res Commun; 1973 Oct; 54(3):1233-9. PubMed ID: 4753192
    [No Abstract]   [Full Text] [Related]  

  • 4. Catechol O-methyltransferase. 7. Affinity labeling with the oxidation products of 6-aminodopamine.
    Borchardt RT; Smissman EE; Nerland D; Reid JR
    J Med Chem; 1976 Jan; 19(1):30-7. PubMed ID: 1246049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol O-methyltransferase. 12. Affinity labeling the active site with the oxidation products of 5,6-dihydroxyindole.
    Borchardt RT; Bhatia P
    J Med Chem; 1982 Mar; 25(3):263-71. PubMed ID: 7069705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labeling of catechol-O-methyltransferase with N-haloacetyl derivatives.
    Borchardt RT; Thakker DR
    Methods Enzymol; 1977; 46():554-61. PubMed ID: 909444
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis of 1-(3,4-dihydroxy-5-nitrophenyl)-2-phenyl-ethanone and derivatives as potent and long-acting peripheral inhibitors of catechol-O-methyltransferase.
    Learmonth DA; Vieira-Coelho MA; Benes J; Alves PC; Borges N; Freitas AP; da-Silva PS
    J Med Chem; 2002 Jan; 45(3):685-95. PubMed ID: 11806720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of catechol-O-methyltransferase by N-(3,4-dihydroxyphenyl) maleimide.
    Piedrafita FJ; Elorriaga C; Fernández-Alvarez E; Nieto O
    J Enzyme Inhib; 1990; 4(1):43-50. PubMed ID: 2128841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic and inhibition studies on catechol-O-methyltransferase affinity labelling by N-(3,4-dihydroxyphenyl)maleimide.
    Piedrafita FJ; Fernandez-Alvarez E; Nieto O; Tipton KF
    Biochem J; 1992 Sep; 286 ( Pt 3)(Pt 3):951-8. PubMed ID: 1417755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies on catechol O-methyltransferase. Product inhibition and the nature of the catechol binding site.
    Coward JK; Slixz EP; Wu FY
    Biochemistry; 1973 Jun; 12(12):2291-7. PubMed ID: 4736330
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular recognition at the active site of catechol-O-methyltransferase (COMT): adenine replacements in bisubstrate inhibitors.
    Ellermann M; Paulini R; Jakob-Roetne R; Lerner C; Borroni E; Roth D; Ehler A; Schweizer WB; Schlatter D; Rudolph MG; Diederich F
    Chemistry; 2011 May; 17(23):6369-81. PubMed ID: 21538606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory Effect of Bovine Lactoferrin on Catechol-O-Methyltransferase.
    Ikeda M; Iijima H; Shinoda I; Iwamoto H; Takeda Y
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28825621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variations in catechol O-methyltransferase activity in rodent tissues: possible role in estrogen carcinogenicity.
    Li SA; Purdy RH; Li JJ
    Carcinogenesis; 1989 Jan; 10(1):63-7. PubMed ID: 2910532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of rat brain and liver solubilized membrane-bound catechol-O-methyltransferase.
    Bonifácio MJ; Vieira-Coelho MA; Borges N; Soares-da-Silva P
    Arch Biochem Biophys; 2000 Dec; 384(2):361-7. PubMed ID: 11368324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of human liver catechol-O-methyltransferase by tea catechins and their metabolites: structure-activity relationship and molecular-modeling studies.
    Chen D; Wang CY; Lambert JD; Ai N; Welsh WJ; Yang CS
    Biochem Pharmacol; 2005 May; 69(10):1523-31. PubMed ID: 15857617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitrocatechol Derivatives of Chalcone as Inhibitors of Monoamine Oxidase and Catechol-O-Methyltransferase.
    Engelbrecht I; Petzer JP; Petzer A
    Cent Nerv Syst Agents Med Chem; 2018; 18(2):115-127. PubMed ID: 29697034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of functional membrane-bound and soluble catechol-O-methyltransferase in Escherichia coli and a mammalian cell line.
    Malherbe P; Bertocci B; Caspers P; Zürcher G; Da Prada M
    J Neurochem; 1992 May; 58(5):1782-9. PubMed ID: 1560233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivatives and alpha-substituted catecholamines.
    Gordonsmith RH; Raxworthy MJ; Gulliver PA
    Biochem Pharmacol; 1982 Feb; 31(3):433-7. PubMed ID: 6803810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dihydroxynitrobenzaldehydes and hydroxymethoxynitrobenzaldehydes: synthesis and biological activity as catechol-O-methyltransferase inhibitors.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    J Med Chem; 1992 Nov; 35(24):4584-8. PubMed ID: 1469689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mechanisms controlling the rate and specificity of catechol O-methylation by human soluble catechol O-methyltransferase.
    Lautala P; Ulmanen I; Taskinen J
    Mol Pharmacol; 2001 Feb; 59(2):393-402. PubMed ID: 11160877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.